Skip to content

Enovis ENOV Income Tax

Income Tax at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$755M-71.3%
Stryker logo
StrykerSYK
$105M-4.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$63M+35.5%
ESAB logo
ESABESAB
$13.11M-36.0%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$56.4M+35.6%
CONMED logo
CONMEDCNMD
$4.53M+177%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's income tax?
Enovis (ENOV) reported income tax of $9.05M in Q1 2026.
How has Enovis's income tax changed year-over-year?
Enovis's income tax increased by 611.3% year-over-year, from -$1.77M to $9.05M.
What is the long-term trend for Enovis's income tax?
Over 3 years (2021 to 2025), Enovis's income tax has grown at a 21.6% compound annual growth rate (CAGR), from -$12.39M to $22.29M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.